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Engineered Neural Tissue as a Substitute for the Autograft in Peripheral 
Nerve Repair 
J. B. Phillips1* 
1
Faculty of Science, The Open University, Milton Keynes, MK7 6AA, UK 
Engineered neural tissue (EngNT) has been developed comprising highly orientated 
Schwann cells that are functionally integrated within an anisotropic collagen matrix. This 
can provide a cellular guidance substrate for peripheral nerve repair when delivered within 
tubular conduits. In vivo tests in the rat sciatic nerve model showed that neurons 
regenerate within EngNT, with fibre diameters and myelin structures that are equivalent to 
those in an autograft (Fig 1). Conduits containing EngNT supported robust axonal growth 
across a 15mm gap and into the distal stump at 8 weeks, whereas empty conduits 
performed poorly in comparison. The Schwann cells within the EngNT provide trophic 
support to the regenerating neurons and are able to modify the extracellular environment 
through remodelling of collagen and deposition of matrix components. Because the 
formation of EngNT involves cells and native collagen fibrils aligning simultaneously via 
natural cell-matrix interactions, the resulting anisotropic material provides a simple tissue-
like structure that can integrate easily with host tissue. The EngNT mimics the key 
structural and functional features of the nerve autograft and can be assembled using 
clinically relevant cells and materials. Autologous and allogeneic stem cells differentiated to 
a Schwann-like phenotype have been incorporated successfully into EngNT and the 
production process is suitable for scale-up and automation. Current research is focussed 
on developing the technology towards clinical application. 
Figure 1: Neuronal regeneration within EngNT, rat sciatic 
nerve injury model, 15mm gap at 8 weeks 
